We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.9B
AUM Growth
+$1.29B
(+3%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$229M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$212M |
| 3 |
Snowflake
SNOW
|
+$211M |
| 4 |
Lam Research
LRCX
|
+$193M |
| 5 |
CME Group
CME
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$282M |
| 2 |
PepsiCo
PEP
|
+$239M |
| 3 |
Walmart Inc
WMT
|
+$236M |
| 4 |
General Motors
GM
|
+$223M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.07B
| $754K | ﹤0.01% |
25,468
+1,775
| +7% | +$51.9K |
|
2102
Acumen Pharmaceuticals
ABOS
$222M
| $752K | ﹤0.01% |
310,797
+132,896
| +75% | +$423K |
|
2103
PubMatic
PUBM
$745M
| $751K | ﹤0.01% |
36,998
+17,571
| +90% | +$392K |
|
2104
Willdan Group
WLDN
$1.27B
| $751K | ﹤0.01% |
26,024
+3,731
| +17% | +$111K |
|
|
EGRX
2105
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $750K | ﹤0.01% |
133,944
-29,491
| -18% | -$128K |
|
2106
Rogers Communications
RCI
$19.7B
| $750K | ﹤0.01% |
20,274
-662,115
| -97% | -$25.7M |
|
2107
Dave & Buster's
PLAY
$362M
| $749K | ﹤0.01% |
+18,810
| New | +$977K |
|
2108
Organogenesis Holdings
ORGO
$215M
| $749K | ﹤0.01% |
267,405
-202,445
| -43% | -$543K |
|
2109
Carter Bankshares
CARE
$719M
| $746K | ﹤0.01% |
49,345
+39,305
| +391% | +$492K |
|
|
BCOV
2110
DELISTED
Brightcove, Inc.
BCOV
| $746K | ﹤0.01% |
314,625
-74,249
| -19% | -$146K |
|
|
CFB
2111
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $746K | ﹤0.01% |
53,177
-8,258
| -13% | -$107K |
|
|
YMAB
2112
DELISTED
Y-mAbs Therapeutics
YMAB
| $741K | ﹤0.01% |
61,316
-42,986
| -41% | -$580K |
|
2113
Cato Corp
CATO
$55.7M
| $739K | ﹤0.01% |
133,405
-6,613
| -5% | -$35.6K |
|
|
SUPV
2114
Grupo Supervielle
SUPV
$749M
| $739K | ﹤0.01% |
108,990
-26,293
| -19% | -$171K |
|
2115
TransAlta
TAC
$3.83B
| $738K | ﹤0.01% |
104,272
-848,495
| -89% | -$5.81M |
|
2116
UNIFI
UFI
$142M
| $738K | ﹤0.01% |
125,251
-38,323
| -23% | -$228K |
|
2117
Resideo Technologies
REZI
$2.93B
| $736K | ﹤0.01% |
37,648
+23,700
| +170% | +$490K |
|
2118
Artisan Partners
APAM
$3.05B
| $734K | ﹤0.01% |
17,777
-5,903
| -25% | -$255K |
|
2119
Plug Power
PLUG
$3.03B
| $732K | ﹤0.01% |
+314,036
| New | +$899K |
|
2120
Natural Gas Services Group
NGS
$448M
| $730K | ﹤0.01% |
+36,266
| New | +$796K |
|
2121
Matrix Service
MTRX
$301M
| $729K | ﹤0.01% |
73,374
-33,768
| -32% | -$386K |
|
2122
1stdibs.com
DIBS
$157M
| $727K | ﹤0.01% |
161,956
+20,626
| +15% | +$113K |
|
|
MREO
2123
Mereo BioPharma
MREO
$46.2M
| $726K | ﹤0.01% |
201,776
-149,953
| -43% | -$486K |
|
|
PPLI
2124
People Inc
PPLI
$2.89B
| $725K | ﹤0.01% |
18,870
-174,969
| -90% | -$7.23M |
|
2125
City Holding Co
CHCO
$2.04B
| $724K | ﹤0.01% |
+6,810
| New | +$700K |
|
Similar funds
John Overdeck's Q2 2024 Portfolio in Review
As of Q2 2024, John Overdeck held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
- John Overdeck added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
- John Overdeck's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
- John Overdeck fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
- John Overdeck opened 479 new positions and closed 480 in Q2 2024.
- John Overdeck's portfolio value rose 3% quarter-over-quarter to $43.9B.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.